Pancreatic Lipase Inhibitory Activity of Saraca Asoca bark Extract

Authors

  • Sweety Tiwari
  • Rajesh Gour
  • Akhlesh Kumar Singhai

DOI:

https://doi.org/10.52783/jns.v14.2419

Keywords:

Pancreatic lipase inhibition, Saraca asoca bark

Abstract

Inhibition of pancreatic lipase is the mechanism that has received the greatest attention from researchers in the search for promising viable anti-obesity ingredients. For the purpose of locating possible anti-obesity drugs, the mechanism that has received the greatest attention from researchers is the inhibition of pancreatic lipase. Orlistat is the only medicine that has been licensed by the Food and Drug Administration (FDA) and is accessible for the treatment of obesity. Other than treatments that reduce obesity by acting on the central nervous system, orlistat is the only drug that inhibits pancreatic lipase. This naturally occurring chemical, known as lipstatin, was the starting point for the discovery of orlistat. The research that is being done to find novel pancreatic lipase inhibitors that do not have any negative side effects has been inspired by the effectiveness of naturally occurring substances that are used for the treatment of obesity. From this point forward, a great number of plant extracts and isolated substances have been found for their ability to inhibit pancreatic lipase. The stem bark of the Asoka tree is astringent, and it also functions as a uterine tonic and has a stimulating impact on the tissue of the ovary and the endometrium. Burning sensations, fever, and dyspepsia are among conditions that may be helped by the bark. This research was conducted to evaluate the methanol and aqueous extracts of Saraca asoca bark for pancreatic lipase inhibition activity.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Aronne LJ. Classification of obesity and assessment of obesity-related health risks. Obesity. 2002;10:105S–115S.

Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature. 2000;404:644–651.

Birari RB, Gupta S, Gopi Mohan C, Bhutani KK. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies. Phytomedicine. 2011;18:795–801.

Bitou N, Ninomiya M, Tsujita T, Okuda H. Screening of lipase inhibitors from marine algae. Lipids. 1999;34:441–445.

Guo Y, Wang H, Gong J, Zhang X, Jiang C. Preparation of benzomacrolides as pancreatic lipase inhibitors. PCT Int Appl. 2011:WO. 2011072623 A1. 20110623.

Seyedan A., Alshawsh MA., Alshagga MA., Koosha S., Mohamed Z. Medicinal plants and their inhibitory activities against pancreatic lipase: a review. Evid Based Complement Altern Med. 2015;2015(9945):1-13.doi:10.1155/2015/973143

Ballinger A., Peikin SR. Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol. 2002;440(2-3):109-117.doi:10.1016/S0014-2999(02)01422-X

Gras J. Cetilistat for the treatment of obesity. Drugs Today. 2013;49(12):755-759.doi:10.1358/dot.2013.49.12.2099318

Nadkarni AK, Nadkarni KM. Indiam Materia Medica (ed). Popular Prakashan-Bombay; India 2005.

Pradhan P, Joseph L, Gupta V, Chulet R, Arya H, Verma R, Bajpai A. Saraca asoca (Ashoka): A Review. Journal of Chemical and Pharmaceutical Research. 2009;1(1):62-71.

Kokate, C.K., Purohit, A.P. and Gohkale, S.B. (2002) Pharmacognosy. In Terpenoids, 21st Edition, Nirali Prakashan, Pune, 377-378.

Tang Y, Zhang B, Li X, Chen PX, Zhang H, Liu R, et al. Bound phenolics of quinoa seeds released by acid, alkaline, and enzymatic treatments and their antioxidant and α-glucosidase and pancreatic lipase inhibitory effects. J Agric Food Chem. (2016) 64:1712–9.

Oluwagunwa OA, Alashi AM, Aluko RE, Inhibition of the in vitro Activities of α-Amylase and Pancreatic Lipase by Aqueous Extracts of Amaranthus viridis, Solanum macrocarpon and Telfairia occidentalis Leaves, Front. Nutr., 2021, 8, 1–17.

Fernando WIT., Attanayake AMKC., Perera HKI, Isolation, identification and characterization of pancreatic lipase inhibitors from Trigonella foenum-graecum seeds. S Afr J Bot. 2019;121:418-421.

Świerczewska A., Buchholz T., Melzig MF., Czerwińska ME. In vitro α-amylase and pancreatic lipase inhibitory activity of Cornus mas L. and Cornus alba L. fruit extracts. J Food Drug Anal. 2019; 27(1): 249-258.

Downloads

Published

2025-03-21

How to Cite

1.
Tiwari S, Gour R, Kumar Singhai A. Pancreatic Lipase Inhibitory Activity of Saraca Asoca bark Extract. J Neonatal Surg [Internet]. 2025Mar.21 [cited 2025Sep.21];14(7S):380-5. Available from: https://jneonatalsurg.com/index.php/jns/article/view/2419

Similar Articles

You may also start an advanced similarity search for this article.